Sponsor:
Medical College of Wisconsin
Code:
NCT06617949
Conditions
Substance Use Disorder (SUD)
Eligibility Criteria
Sex: Female
Age: 18 - 40
Healthy Volunteers: Not accepted
Interventions
Regional Anesthesia
Hydromorphone Patient Controlled Analgelsic
Epidural local anesthetic infusion
Brief summary:
Conditions
Substance Use Disorder (SUD)
Study ID
NCT06617949
Start date
Jan 16, 2025
Status verified date
Oct, 2025
Completion date
Dec, 2028
Anticipated
Primary completion date
Dec, 2027
Anticipated
Eligibility Criteria
Sex: Female
Age: 18 - 40
Healthy Volunteers: Not accepted
Enrollment
20 participants
Anticipated
Allocation
Non randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
active comparator: Transverse abdominal Plane(TAP) Block with long acting Exparel
active comparator: Postoperative Epidural infusion for 24-36hrs
active comparator: Hydromorphone Patient Controlled Analgesia (PCA),Preservative free Morphine via epidural for 36hrs
Interventions
Regional Anesthesia
Hydromorphone Patient Controlled Analgelsic
Epidural local anesthetic infusion
Primary outcome measure
Central contacts
Locations
Froedtert Hospital Milwaukee, Wisconsin 53226
Recruiting
Milwaukee, Wisconsin, United States, 53226
Sponsor
Medical College of Wisconsin
Last update posted
Oct 23, 2025
Last verified
Oct, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Medical College of Wisconsin on 2025-10-23.